Latest Insider Transactions at Charles River Laboratories International, Inc. (CRL)
This section provides a real-time view of insider transactions for Charles River Laboratories International, Inc. (CRL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 27
2022
|
William D Barbo Corporate Executive VP & CCO |
BUY
Grant, award, or other acquisition
|
Direct |
1,493
+24.88%
|
-
|
|
May 27
2022
|
Victoria L Creamer EVP & Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,493
+11.7%
|
-
|
|
May 27
2022
|
Michael Gunnar Knell CSVP&Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
491
+6.99%
|
-
|
|
May 27
2022
|
Birgit Girshick Corporate Executive VP & COO |
BUY
Grant, award, or other acquisition
|
Direct |
2,455
+6.36%
|
-
|
|
May 27
2022
|
Joseph W La Plume EVP, Corp Strategy & Develop |
BUY
Grant, award, or other acquisition
|
Direct |
1,657
+7.15%
|
-
|
|
May 11
2022
|
Nancy C Andrews Director |
BUY
Grant, award, or other acquisition
|
Direct |
575
+24.26%
|
-
|
|
May 11
2022
|
Robert J Bertolini Director |
BUY
Grant, award, or other acquisition
|
Direct |
980
+1.58%
|
-
|
|
May 11
2022
|
Deborah Turner Kochevar Director |
BUY
Grant, award, or other acquisition
|
Direct |
575
+7.94%
|
-
|
|
May 11
2022
|
George Llado Sr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
867
+20.58%
|
-
|
|
May 11
2022
|
George Massaro Director |
BUY
Grant, award, or other acquisition
|
Direct |
575
+9.87%
|
-
|
|
May 11
2022
|
C Richard Reese Director |
BUY
Grant, award, or other acquisition
|
Direct |
957
+0.74%
|
-
|
|
May 11
2022
|
Richard F Wallman Director |
BUY
Grant, award, or other acquisition
|
Direct |
935
+2.48%
|
-
|
|
May 11
2022
|
Virginia M Wilson Director |
BUY
Grant, award, or other acquisition
|
Direct |
575
+17.33%
|
-
|
|
May 11
2022
|
Martin Mackay Director |
BUY
Grant, award, or other acquisition
|
Direct |
841
+3.9%
|
-
|
|
May 09
2022
|
George Massaro Director |
SELL
Open market or private sale
|
Direct |
178
-0.53%
|
$41,296
$232.4 P/Share
|
|
May 02
2022
|
Flavia Pease Corporate Executive VP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
5,185
+50.0%
|
-
|
|
Mar 11
2022
|
William D Barbo Corporate Executive VP & CCO |
BUY
Bona fide gift
|
Indirect |
754
+3.85%
|
-
|
|
Mar 11
2022
|
William D Barbo Corporate Executive VP & CCO |
SELL
Bona fide gift
|
Direct |
754
-20.01%
|
-
|
|
Mar 03
2022
|
David Ross Smith Corporate Executive VP & CFO |
SELL
Open market or private sale
|
Direct |
8,965
-5.72%
|
$2,537,095
$283.44 P/Share
|
|
Mar 03
2022
|
David Ross Smith Corporate Executive VP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,965
+8.51%
|
$1,290,960
$144.56 P/Share
|
|
Feb 28
2022
|
David Ross Smith Corporate Executive VP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
5,152
+16.63%
|
-
|
|
Feb 23
2022
|
James C Foster Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
20,296
-0.69%
|
$5,865,544
$289.88 P/Share
|
|
Feb 23
2022
|
James C Foster Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,296
+7.94%
|
$2,212,264
$109.34 P/Share
|
|
Feb 23
2022
|
Joseph W La Plume EVP, Corp Strategy & Develop |
SELL
Open market or private sale
|
Direct |
395
-1.95%
|
$115,340
$292.75 P/Share
|
|
Feb 23
2022
|
David Ross Smith Corporate Executive VP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
374
-1.78%
|
$108,086
$289.58 P/Share
|
|
Feb 23
2022
|
Birgit Girshick Corporate Executive VP & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
280
-0.82%
|
$80,920
$289.58 P/Share
|
|
Feb 23
2022
|
Michael Gunnar Knell CSVP&Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
56
-0.92%
|
$16,184
$289.58 P/Share
|
|
Feb 23
2022
|
James C Foster Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,770
-0.82%
|
$511,530
$289.58 P/Share
|
|
Feb 23
2022
|
Joseph W La Plume EVP, Corp Strategy & Develop |
SELL
Payment of exercise price or tax liability
|
Direct |
315
-1.53%
|
$91,035
$289.58 P/Share
|
|
Feb 23
2022
|
William D Barbo Corporate Executive VP & CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
315
-7.71%
|
$91,035
$289.58 P/Share
|
|
Feb 22
2022
|
David Ross Smith Corporate Executive VP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
341
-1.59%
|
$99,913
$293.61 P/Share
|
|
Feb 22
2022
|
Victoria L Creamer EVP & Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
180
-1.81%
|
$52,740
$293.61 P/Share
|
|
Feb 22
2022
|
Birgit Girshick Corporate Executive VP & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
274
-0.8%
|
$80,282
$293.61 P/Share
|
|
Feb 22
2022
|
Michael Gunnar Knell CSVP&Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
51
-0.83%
|
$14,943
$293.61 P/Share
|
|
Feb 22
2022
|
James C Foster Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
17,436
-0.96%
|
$5,039,004
$289.37 P/Share
|
|
Feb 22
2022
|
James C Foster Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,436
+6.93%
|
$2,510,784
$144.67 P/Share
|
|
Feb 22
2022
|
James C Foster Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,610
-0.74%
|
$471,730
$293.61 P/Share
|
|
Feb 22
2022
|
Richard F Wallman Director |
SELL
Open market or private sale
|
Indirect |
3,250
-100.0%
|
$936,000
$288.05 P/Share
|
|
Feb 22
2022
|
Joseph W La Plume EVP, Corp Strategy & Develop |
SELL
Open market or private sale
|
Direct |
396
-0.94%
|
$114,840
$290.82 P/Share
|
|
Feb 22
2022
|
Joseph W La Plume EVP, Corp Strategy & Develop |
SELL
Payment of exercise price or tax liability
|
Direct |
317
-1.49%
|
$92,881
$293.61 P/Share
|
|
Feb 22
2022
|
William D Barbo Corporate Executive VP & CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
287
-6.57%
|
$84,091
$293.61 P/Share
|
|
Feb 18
2022
|
Richard F Wallman Director |
SELL
Open market or private sale
|
Direct |
1,150
-3.1%
|
$339,250
$295.0 P/Share
|
|
Feb 18
2022
|
Richard F Wallman Director |
SELL
Open market or private sale
|
Indirect |
2,800
-46.28%
|
$831,600
$297.5 P/Share
|
|
Feb 18
2022
|
Joseph W La Plume EVP, Corp Strategy & Develop |
SELL
Open market or private sale
|
Direct |
1,143
-5.1%
|
$332,613
$291.8 P/Share
|
|
Feb 18
2022
|
Joseph W La Plume EVP, Corp Strategy & Develop |
BUY
Exercise of conversion of derivative security
|
Direct |
743
+3.21%
|
$65,384
$88.05 P/Share
|
|
Feb 15
2022
|
James C Foster Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
20,000
-0.4%
|
$6,400,000
$320.77 P/Share
|
|
Feb 14
2022
|
Joseph W La Plume EVP, Corp Strategy & Develop |
SELL
Bona fide gift
|
Direct |
150
-0.69%
|
-
|
|
Feb 08
2022
|
William D Barbo Corporate Executive VP & CCO |
BUY
Bona fide gift
|
Indirect |
6,178
+25.46%
|
-
|
|
Feb 08
2022
|
William D Barbo Corporate Executive VP & CCO |
SELL
Bona fide gift
|
Direct |
6,178
-58.56%
|
-
|
|
Feb 01
2022
|
Victoria L Creamer EVP & Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
343
-3.33%
|
$112,847
$329.76 P/Share
|